Immuneering Corp
IMRX· Nasdaq
IMRXImmuneering Corp
Quarterly figures for Immuneering Corp, with source filings when available.
26 quarters. Mar 31, 2020 to Jun 30, 2026. USD.
Immuneering Corp has filed its 10-Q within 35 to 45 days of period end across its last 8 quarters. The 10-K runs 61 to 79 days.
Immuneering Corp · CIK 1790340 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 5, 2026 · pre-market | Aug 5, 2026 | 36 d | 10-Q | — | — | -$0.27 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 15, 2026 · pre-market |
| May 15, 2026 |
| 45 d |
| 10-Q |
| — |
| — |
| -$0.21 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 6, 2026 · pre-market | Mar 6, 2026 | 65 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 · after-hours | Nov 12, 2025 | 43 d | 10-Q | — | — | -$0.38 | |
| Q2 2025 | Jun 30, 2025 | Aug 13, 2025 · after-hours | Aug 13, 2025 | 44 d | 10-Q | — | — | -$0.40 | |
| Q1 2025 | Mar 31, 2025 | May 5, 2025 · after-hours | May 5, 2025 | 35 d | 10-Q | — | — | -$0.42 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 20, 2025 · after-hours | Mar 20, 2025 | 79 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · after-hours | Nov 13, 2024 | 44 d | 10-Q | — | — | -$0.49 | |
| Q2 2024 | Jun 30, 2024 | Aug 6, 2024 · after-hours | Aug 6, 2024 | 37 d | 10-Q | — | — | -$0.47 | |
| Q1 2024 | Mar 31, 2024 | May 7, 2024 · after-hours | May 7, 2024 | 37 d | 10-Q | — | — | -$0.49 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 1, 2024 · pre-market | Mar 1, 2024 | 61 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 · after-hours | Nov 9, 2023 | 40 d | 10-Q | $0.00 | −100.0% | -$0.43 | |
| Q2 2023 | Jun 30, 2023 | Aug 3, 2023 · after-hours | Aug 3, 2023 | 34 d | 10-Q | $0.00 | −100.0% | -$0.43 | |
| Q1 2023 | Mar 31, 2023 | Apr 18, 2023 · pre-market | May 4, 2023 | 34 d | 10-Q | $0.00 | −100.0% | -$0.51 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 6, 2023 · after-hours | Mar 6, 2023 | 65 d | 10-K | $455.00 | −99.8% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 10, 2022 · pre-market | Nov 10, 2022 | 41 d | 10-Q | $38.38K | −92.0% | -$0.49 | |
| Q2 2022 | Jun 30, 2022 | Aug 10, 2022 · after-hours | Aug 10, 2022 | 41 d | 10-Q | $94.42K | −85.7% | -$0.44 | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · pre-market | May 10, 2022 | 40 d | 10-Q | $183.70K | −75.4% | -$0.49 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 10, 2022 · pre-market | Mar 10, 2022 | 69 d | 10-K | $189.59K | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 9, 2021 | 40 d | 10-Q | $482.13K | −29.4% | -$0.47 | |
| Q2 2021 | Jun 30, 2021 | — | Sep 9, 2021 | 71 d | 10-Q | $660.04K | +37.3% | -$1.61 | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | $748.20K | — | -$1.26 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | $682.57K | — | -$0.89 | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $480.84K | — | -$0.73 | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | — | — | — | |
